C-Met tyrosine kinase receptor expression and function in human and canine osteosarcoma cells

被引:0
|
作者
MacEwen, EG
Kutzke, J
Carew, J
Pastor, J
Schmidt, JA
Tsan, R
Thamm, DH
Radinsky, R
机构
[1] Univ Wisconsin, Sch Vet Med, Dept Med Sci, Madison, WI 53706 USA
[2] Univ Wisconsin, Ctr Comprehens Canc, Madison, WI USA
[3] Univ Texas, MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA
关键词
c-Met; canine; human; osteosarcoma; hepatocyte growth factor; invasion; molecular determinants; scatter factor; urokinase plasminogen activator;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To further characterize the role of hepatocyte growth factor-scatter factor (HGF-SF) and its receptor (c-Met) in osteosarcoma (OS), human OS cell lines with low (SAOS-2) and high (SAOS-LM2) metastatic potential, and cell lines derived from spontaneous canine OS were studied. All cell lines were evaluated for c-Met and HGF-SF expression and receptor activation using Northern, RT-PCR, and Western blot analyses, respectively. Functional activity of receptor-ligand interaction was measured using c-Met phosphorylation status, proliferation assays (anchorage-dependent and - independent), Matrigel invasion, modulation of urokinase plasminogen activator (uPA) expression, and cell dispersion ( scattering). All cell lines exhibited steady-state mRNA expression of c-Met. The canine OS cell lines also expressed HGF-SF mRNA as determined by RT-PCR analysis. Western analysis showed c-Met protein expression and HGF-stimulated ( human) or constitutive ( canine) receptor autophosphorylation. Treatment with recombinant human HGF resulted in enhanced proliferation in 3 of 5 OS cell lines and enhanced colony formation in 2 of 5 OS cell lines. Matrigel invasion was significantly enhanced in 3 of the cell lines and uPA levels were significantly increased in the SAOS-2 cells following HGF treatment. Scattering was enhanced in both the SAOS-2 and SAOS-LM2 cells. These data support the involvement of c-Met and HGF-SF in the growth and progression of human and canine OS, and may offer new targets for the development of therapeutic strategies for OS.
引用
收藏
页码:421 / 430
页数:10
相关论文
共 50 条
  • [21] c-met tyrosine kinase receptor expression is associated with abnormal β-catenin expression and favourable prognostic factors in invasive breast carcinoma
    Nakopoulou, L
    Gakiopoulou, H
    Keramopoulos, A
    Giannopoulou, I
    Athanassiadou, P
    Mavrommatis, J
    Davaris, PS
    HISTOPATHOLOGY, 2000, 36 (04) : 313 - 325
  • [22] Therapeutic potential of tyrosine-protein kinase MET in osteosarcoma
    Zeng, Ming
    Liu, Can
    Gong, Haoli
    Tang, Zhongwen
    Wen, Jie
    Wang, Sisi
    Xiao, Sheng
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2024, 11
  • [23] From Concept to Reality: The Long Road to c-Met and RON Receptor Tyrosine Kinase Inhibitors for the Treatment of Cancer
    Dussault, Isabelle
    Bellon, Steven F.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2009, 9 (02) : 221 - 229
  • [24] Expression of hepatocyte growth factor and its receptor c-Met in human pituitary adenomas
    Hou, Xian-Zeng
    Liu, Wei
    Fan, Hai-Tao
    Liu, Bin
    Pang, Bo
    Xin, Tao
    Xu, Shang-Chen
    Pang, Qi
    NEURO-ONCOLOGY, 2010, 12 (08) : 799 - 803
  • [25] The c-MET receptor tyrosine kinase contributes to neutrophil-driven pathology in cutaneous leishmaniasis
    Passelli, Katiuska
    Prat-Luri, Borja
    Merlot, Margot
    Goris, Michiel
    Mazzone, Massimiliano
    Tacchini-Cottier, Fabienne
    PLOS PATHOGENS, 2022, 18 (01)
  • [26] Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c-MET Limit Cancer Immunotherapy
    Glodde, Nicole
    Bald, Tobias
    van den Boorn-Konijnenberg, Debby
    Nakamura, Kyohei
    O'Donnell, Jake S.
    Szczepanski, Sabrina
    Brandes, Maria
    Eickhoff, Sarah
    Das, Indrajit
    Shridhar, Naveen
    Hinze, Daniel
    Rogava, Meri
    van der Sluis, Tetje C.
    Ruotsalainen, Janne J.
    Gaffal, Evelyn
    Landsberg, Jennifer
    Ludwig, Kerstin U.
    Wilhelm, Christoph
    Riek-Burchardt, Monika
    Mueller, Andreas J.
    Gebhardt, Christoffer
    Scolyer, Richard A.
    Long, Georgina V.
    Janzen, Viktor
    Teng, Michele W. L.
    Kastenmueller, Wolfgang
    Mazzone, Massimiliano
    Smyth, Mark J.
    Tueting, Thomas
    Hoelzel, Michael
    IMMUNITY, 2017, 47 (04) : 789 - +
  • [27] Role of the expression of c-Met receptor in the progression of gastric cancer
    Amemiya, Hideki
    Menolascino, Francisco
    Pena, Alix
    INVESTIGACION CLINICA, 2010, 51 (03): : 369 - 380
  • [28] Expression of the HGF/SF receptor, c-met, and its ligand in human colorectal cancers
    Hiscox, SE
    Hallett, MB
    Puntis, MCA
    Nakamura, T
    Jiang, WG
    CANCER INVESTIGATION, 1997, 15 (06) : 513 - 521
  • [29] Tyrosine Kinase Receptor Expression in Canine Liposarcoma
    Avallone, G.
    Pellegrino, V.
    Roccabianca, P.
    Lepri, E.
    Crippa, L.
    Beha, G.
    De Tolla, L.
    Sarli, G.
    VETERINARY PATHOLOGY, 2017, 54 (02) : 212 - 217
  • [30] Anticancer effect of crizotinib on osteosarcoma cells by targeting c-Met signaling pathway
    Jia, Tao
    Cai, Mengmeng
    Wang, Zengkun
    Chen, Tianxin
    CELLULAR AND MOLECULAR BIOLOGY, 2023, 69 (05) : 174 - 178